Literature DB >> 308514

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

J J Twomey, A H Laughter, A D Steinberg.   

Abstract

Normal mononuclear leukocytes were incubated with serum from patients with active systemic lupus erythematosus (SLE) and healthy subjects and then studied on lymphoproliferative tests. Serum from SLE patients that contained an autoantibody to a subpopulation of thymus-derived (T) lymphocytes inhibited suppressor T-cell activity induced with concanavalin A. These sera did not inhibit lymphoproliferative responses or suppression by monocytoid cells. Mitogen-activated suppressor cells were not inhibited with serum from SLE patients or healthy subjects lacking T-cell autoantibody. This abnormality may contribute to the altered immune response that occurs with SLE.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308514      PMCID: PMC371819          DOI: 10.1172/JCI109180

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus.

Authors:  N I Abdou; A Sagawa; E Pascual; J Hebert; S Sadeghee
Journal:  Clin Immunol Immunopathol       Date:  1976-09

2.  Selective loss of suppressor cell function in New Zealand mice induced by NTA.

Authors:  L W Klassen; R S Krakauer; A D Steinberg
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Immunosuppression in man: suppression by macrophages can be mediated by interactions with regulatory T cells.

Authors:  J D Stobo
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium.

Authors:  S Horowitz; W Borcherding; A V Moorthy; R Chesney; H Schulte-Wisserman; R Hong
Journal:  Science       Date:  1977-09-02       Impact factor: 47.728

6.  Lymphocyte-dependent antibody-mediated cytolysis of DNA-anti-DNA-coated target cells using human and murine SLE effector populations.

Authors:  M E Gershwin; W Glinski; T Chused; A D Steinberg
Journal:  Clin Immunol Immunopathol       Date:  1977-09

7.  Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient.

Authors:  W Glinski; M E Gershwin; D R Budman; A D Steinberg
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

8.  Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE.

Authors:  D R Budman; E B Merchant; A D Steinberg; B Doft; M E Gershwin; E Lizzio; J P Reeves
Journal:  Arthritis Rheum       Date:  1977-04

9.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

10.  Suppression of lymphoproliferation by high concentrations of normal human mononuclear leukocytes.

Authors:  A H Laughter; J J Twomey
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

View more
  21 in total

1.  Immunosuppressive actions of prostaglandins and the possible increase in chronic inflammation after cyclo-oxygenase inhibitors.

Authors:  G P Lewis; M L Barrett
Journal:  Agents Actions       Date:  1986-10

2.  Detection of antilymphocyte antibody with two-color method in systemic lupus erythematosus and its heterogeneous specificities against human T-cell subsets.

Authors:  K Okudaira; H Nakai; T Hayakawa; T Kashiwado; K Tanimoto; Y Horiuchi; T Juji
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

Review 3.  Immunopathogenesis of the neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein; K D Pischel; V L Woods
Journal:  Springer Semin Immunopathol       Date:  1986

Review 4.  Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.

Authors:  J B Winfield; P Fernsten; J Czyzyk; E Wang; J Marchalonis
Journal:  Springer Semin Immunopathol       Date:  1994

5.  Production of pemphigus antibody in vitro and analysis of T-cell subsets.

Authors:  A R Ahmed; R I Murahata; R W Schroff; R M Stevens; A S Saxon
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

Review 6.  In vitro antibody response of human lymphocytes.

Authors:  C J Heijnen; F UytdeHaag; R E Ballieux
Journal:  Springer Semin Immunopathol       Date:  1980-05

7.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.

Authors:  A Sagawa; N I Abdou
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

9.  Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.

Authors:  S Kumagai; A D Steinberg; I Green
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

10.  Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE.

Authors:  G M Bahr; G A Rook; E Moreno; P M Lydyard; F Z Modabber; J L Stanford
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.